Search Videos and More

Showing 361 - 368 of 368 results

Previous| 1... 29 | 30 | 31 |Next


First Mammography Screening Guidelines Issued for Older Survivors of Breast Cancer News

First Mammography Screening Guidelines Issued for Older Survivors of Breast Cancer

A nationwide panel of experts has developed the first mammography guidelines for older survivors of breast cancer, providing a framework for discussions between survivors and their physicians on the pros and cons of screening in survivors’ later years.
Dana-Farber Research Supports FDA Approval for Immunotherapy Combination in Advanced Kidney Cancer News

Dana-Farber Research Supports FDA Approval for Immunotherapy Combination in Advanced Kidney Cancer

An immunotherapy agent combined with a tyrosine kinase inhibitor drug whose clinical testing as a first-line treatment in advanced kidney cancer was led by Toni K. Choueiri, MD, Director of the Lank Center for Genitourinary Oncology at Dana-Farber Cancer Institute, has become a standard therapy.
Personalized Vaccine Produces Long-Lasting Anti-Tumor Response in Patients with Melanoma, Study Shows News

Personalized Vaccine Produces Long-Lasting Anti-Tumor Response in Patients with Melanoma, Study Shows

Four years after patients with melanoma were treated with a personalized cancer vaccine, the immune response kindled by the vaccine remains robust and effective in keeping cancer cells under control, researchers at Dana-Farber Cancer Institute, Brigham and Women’s Hospital, and the Broad Institute of MIT and Harvard report in a new study.
Study Shows Sharp Decline in Cancer Screenings and Diagnoses During the First Covid-19 Surge News

Study Shows Sharp Decline in Cancer Screenings and Diagnoses During the First Covid-19 Surge

In one of the first studies to examine the impact of the COVID-19 pandemic on cancer diagnoses, researchers at Dana-Farber/Brigham and Women’s Cancer Center document a substantial decline in cancer and precancer diagnoses at the Northeast’s largest health care system during the first peak of the pandemic because of a drop in the number of cancer screening tests performed.
Eric P. Winer Elected ASCO President for Term Starting in June 2022 News

Eric P. Winer Elected ASCO President for Term Starting in June 2022

The American Society of Clinical Oncology (ASCO) has elected Eric P. Winer, MD, to serve as its President for the term beginning in June 2022. He will take office as President-Elect during the ASCO Annual Meeting in June 2021. Winer is the chief clinical development officer, senior vice president for medical affairs, chief of the Division of Breast Oncology, and the Thompson Chair in Breast Cancer Research at Dana-Farber Cancer Institute. He is also a professor of medicine at Harvard Medical School.
Dana-Farber Research Looks at Blood Test to Detect Cancer Video

Dana-Farber Research Looks at Blood Test to Detect Cancer

Dana-Farber’s Deborah Schrag, MD, MPH, is leading the Pathfinder Study, a study that looks at a simple blood test and evaluates it to see if it could detect multiple cancer types at the earliest and most treatable stages.
Communicating With Families of Seriously Ill Patients with COVID-19: What are The Guidelines? Which Models Can Help You Manage These Difficult Conversations? Video

Communicating With Families of Seriously Ill Patients with COVID-19: What are The Guidelines? Which Models Can Help You Manage These Difficult Conversations?

Richard Leiter, MD, MA, presents on patients with Covid-19 and how to communicate with their families and how to have difficult conversations.
Myeloma Patients Covid-19: How to Keep Myeloma Care Safe During the Pandemic Video

Myeloma Patients Covid-19: How to Keep Myeloma Care Safe During the Pandemic

Nikhil Munshi, MD, discusses Covid-19 and Myeloma, the understanding the disease, how to make the treatments safer all while being aware of Covid-19 protocols.

Showing 361 - 368 of 368 results

Previous| 1... 29 | 30 | 31 |Next